Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02615756
Other study ID # 19/180/2013
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2013
Est. completion date June 2018

Study information

Verified date March 2021
Source Turku University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, we use positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) to study brain mechanisms that contribute to physical exercise-induced reward. We examine whether acute physical exercise releases endogenous opioids in the brain, and whether it modulates brain responses to viewing appetizing foods. Unraveling these mechanism are instrumental from a public health perspective, given the undisputed positive health effects of physical exercise.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date June 2018
Est. primary completion date June 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Native Finnish speaker 2. Age > 18 years 3. Western Caucasian origin Exclusion Criteria: 1. Age < 18 or > 65 2. History or current mental disorder 3. BMI > 27 kg/m2 4. Use of drugs that influence the central nervous system, including nicotine 5. Poor compliance 6. Any chronic medical defect or injury which hinder or interfere everyday life 7. Eating disorder 8. Current or past excessive use of alcohol or substance abuse 9. Past dose of radiation from medical research such that the annual effective dose will exceed 10 mSv 10. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results 11. Presence of any ferromagnetic objects that would make MR imaging contraindicated

Study Design


Related Conditions & MeSH terms

  • Physical Exercise Behavior (Liking/Aversion)

Intervention

Behavioral:
Exercise


Locations

Country Name City State
Finland Turku PET Centre Turku

Sponsors (5)

Lead Sponsor Collaborator
Turku University Hospital Academy of Finland, Juho Vainio Foundation, Novo Nordisk A/S, University of Turku

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Binding of [11C]carfentanil in brain confirmed by positron emission tomography Change in binding of [11C]carfentanil in baseline and 20 min after physical exercise completion Baseline and 20 min after physical exercise completion